메뉴 건너뛰기
Library Notice
Institutional Access
If you certify, you can access the articles for free.
Check out your institutions.
ex)Hankuk University, Nuri Motors
Log in Register Help KOR
Subject

An Analysis on the Determinants of Efficiency of the Pharmaceutical Firms using Stochastic Frontier Analysis
Recommendations
Search

Stochastic Frontier Analysis를 이용한 제약회사의 효율성과 그 결정요인분석

논문 기본 정보

Type
Academic journal
Author
Sakong, Jin (한양대학교) Kim, Jeongkyu (한국개발연구원 규제연구센터)
Journal
Korea Academy of Health Policy and Management 보건행정학회지 보건행정학회지 제25권 제2호 KCI Accredited Journals
Published
2015.1
Pages
97 - 106 (10page)

Usage

cover
An Analysis on the Determinants of Efficiency of the Pharmaceutical Firms using Stochastic Frontier Analysis
Ask AI
Recommendations
Search

Abstract· Keywords

Report Errors
Background & Methods: The purpose of this research is to estimate the efficiency of the pharmaceutical firms and the determinants of their efficiency. Stochastic frontier analysis(SFA) and panel study are applied to the data of 60 domestic pharmaceutical firms from 2006 to 2012. Results & Conclusion: First, the result of the stochastic frontier analysis shows that overall efficiency of the pharmaceutical firms is increasing as time goes by. However, if firms are classified by the scale, the larger firms show more efficiency and if classified by the degree of innovativeness, the innovative firms show more efficiency compared to the non-innovative firms. This evidences show that the scale and R&D investment have significant relationships with the efficiency of the pharmaceutical firms. Therefore, it is necessary to increase the national level of investment for the fundamental researches to vitalize R&D of the new drugs. Second, the result of estimation of the determinants of efficiency shows that the firms with larger sales promotion expenses and entertainment expenses have less efficiency compared to the other firms. This can be explained by the structural characteristics of the small generic pharmaceutical firms. Therefore, the government had better make the pharmaceutical firms to reduce sales promotion and entertainment expenses and increase R&D expenses by introducing systems such as global budgeting system on medicine or reference pricing system.

Contents

No content found

References (36)

Add References

Recommendations

It is an article recommended by DBpia according to the article similarity. Check out the related articles!

Related Authors

Recently viewed articles

Comments(0)

0

Write first comments.